Skip to content
healthcare.dev

Katerzia

NDC 52652-5001, Amlodipine, suspension, from Azurity Pharmaceuticals, Inc..

Product NDC
52652-5001
Status
Listed
Labeler
Azurity Pharmaceuticals, Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA211340
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/52652-5001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMLODIPINE BENZOATE1 mg/mL

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]

Package NDCNDC-11Package
52652-5001-1526525001011 BOTTLE in 1 CARTON (52652-5001-1) / 150 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/df673a4d-acb8-444c-a472-c87ab8cbd366
  • NADAC price for package 52652500101

    GET /v1/drugs/nadac/52652500101

Use it

Look up 52652-5001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/52652-5001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 52652-5001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.